Four-year visual outcomes in the protocol W randomized trial of intravitreous aflibercept for prevention of vision-threatening complications of diabetic retinopathy
Maturi RK, Glassman AR, Josic K, et al.
JAMA. 2023;329(5):376-385.
Leggi
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Maturi RK, Glassman AR, Josic K, et al.
JAMA. 2023;329(5):376-385.
Leggi
Igudesman D, Crandell J, Corbin KD, et al.
Nutr Metab Cardiovasc Dis. 2023;33(2):388-398.
Leggi
Poli A, Catapano AL, Corsini A, et al.
Nutr Metab Cardiovasc Dis. 2023;33(2):245-257.
Leggi
Frias J, Chien J, Zhang Q, et al.
Lancet Diabetes Endocrinol. Pub. online 6 Feb 2023.
Leggi
Feig DS, Sanchez JJ, Murphy KE, et al.
Lancet Diabetes Endocrinol. 2023;S2213-8587(23)00004-9.
Leggi
Laffel LM, Danne T, Klingensmith GJ, et al.
Lancet Diabetes Endocrinol. 2023;S2213-8587(22)00387-4.
Leggi
D’Andrea E, Wexler DJ, Kim SC, et al.
JAMA Intern Med. Pub. online 6 Feb 2023.
Leggi
Urbina EM, Isom S, Dabelea D, et al.
Diabetes Care. 2023;dc221703.
Leggi
Liu B, Liu J, Pan J, et al.
BMC Endocr Disord. 2023;23(1):27.
Leggi
Zheng D, Li N, Hou R, et al.
BMC Med. 2023 Feb 3;21(1):40
Leggi